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Placebo-Controlled, Randomized Trial.” 
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We thank the authors for their interesting and valuable comments on our recent published 
article: “The addition of Platelet-rich Plasma to facial lipofilling: A Double-Blind, Placebo-
Controlled, Randomized Trial.”1 We fully agree with their comment that future prospectively 
randomised clinical studies are warranted to evaluate the concentration-dependent effect of 
Platelet-rich Plasma (PRP) on adipose derived stromal cells (ASC) in combination with facial 
lipofilling.
2
 However, some of their other well appreciated comments need to be addressed.  
 In our prospective study presented, we concluded that the addition of PRP to facial 
lipofilling significantly reduced postoperative recovery time but did not improve clinical 
parameters like skin elasticity and patient satisfaction.
1
 Though, a regression analysis of the 
true skin elasticity as a function of age showed a negative correlation preoperative. After 
applying facial lipofilling with and without PRP the correlation reversed, with a stronger 
positive correlation in the PRP group. This difference was, however, not significant, possible 
due to the small sample size. In this study, PRP was mixed with adipose tissue in a 12:1 ratio. 
In an earlier retrospective study (2014) published by our group, we found that the addition of 
PRP to facial lipofilling in combination with or without a MACS-lift also significantly 
reduced recovery time. In contrast to our prospective study presented, also an improved 
aesthetic outcome was observed. In this retrospective study, PRP was mixed with adipose 
tissue in a 10:1 ratio.
3
 
The authors state that the lack of significance of the effect observed in our prospective 
trial might be due to decreased PRP concentrations relative to the amount of adipose tissue.
2
 
The slightly different ratio in our prospective study cannot, to our opinion, explain the 
difference in aesthetic outcome; this latter has to be ascribed to the retrospective nature of 
this study without the use of more objective and validated instruments like the cutometer.
4
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 In our latest in vitro study we found that a high concentration of PRP (i.e. 
15%) resulted in an eight-fold increased proliferation of ASC.
5
 However, as the authors 
mentioned, a lower concentration of PRP (i.e. 5% PRP) was shown to be more beneficial for 
wound healing purposes as compared to the higher concentration of PRP.
5
 A lower 
concentration of PRP resulted in an increased expression of genes that encode paracrine 
factors by ASC such as collagen 1, matrix metalloproteinase (MMP) 1 and 2 as well as a 
decreased gene expression of tissue inhibitor metalloproteinase 1 (TIMP1).  Collagen 1 is 
important in dermal scar formation, while MMP1 as well as MMP2 are essential natural 
collagenases which are key players in tissue remodelling. Moreover, MMP1 and MMP2 are 
inhibited by TIMP1 and therefore a reduced expression of TIMP1 may augment tissue 
remodelling.
5
 Based on the aforementioned reasons, it might even be possible that the 
concentration of PRP used in the prospective trial was too high and a lower concentration of 
PRP should have been used. Nevertheless, we caution that the clinical translation of the 
results of our previous in vitro study with PRP is at best an educated guess. The ASC in our 
study were cultured, which means that their phenotype differs from their tissue-resident 
precursors. We cannot presume that PRP influences the proliferation of tissue-resident ASC, 
while their secreted products may be influenced as is the production of secreted factors by 
other tissue-resident cells such as fibroblasts, smooth muscle cells, endothelial cells and 
adipocytes too. The net effect of exogenously administered PRP is the sum of the influences 
on everyone of the cell types. It is a flaw of reasoning to reduce the efficacy of lipoaspirates 
to their ASC precursors. 
 There is quite obvious a definite need for more prospective randomized clinical trials 
to evaluate the effect of different concentrations of PRP on facial lipofilling. Up till then, we 
can only conclude that PRP mixed to facial lipofilling (12:1) will only shorten recovery time, 
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